Tuberculosis in Children With Primary Immunodeficiencies: A 13‐Year Retrospective Experience
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71457 ↗At a glance
Journal article in Pediatric Pulmonology, 2026. Written by Hincal Ozbakir and 12 co-authors. Institution: Department of Pediatric Infectious Diseases, University of Health Sciences Dr. Behçet Uz Children's Hospital, İzmir, Turkey. Major MEDLINE topics: Tuberculosis, Primary Immunodeficiency Diseases, Immunologic Deficiency Syndromes. 22 references.
Topics: Kinderkrankenpflege
Abstract (original language)
Background
The primary risk factor determining the progression of tuberculosis (TB) infection is the host's immune status. However, reports of TB cases in children diagnosed with primary immunodeficiency (PID), also referred to as inborn errors of immunity (IEI), remain scarce. In this study, we describe the impact of PID/IEI on childhood TB disease.
Methods
In this retrospective cohort study, data of patients aged 1 month to 18 years who were diagnosed with TB between January 2012 and January 2025 were collected. TB patients were compared according to PID status. Additionally, radiological, histopathological, and microbiological diagnostic findings, as well as clinical features and treatments of TB patients with PID, were evaluated.
Results
A total of 217 TB patients were included, with a median age of 118 months (IQR: 42–169.5). PID was detected in 5.5% ( n = 12) of the patients. In 6 (50%) of the PID patients, the immunodeficiency was not known before the TB diagnosis. The median age of patients with PID was 17 months (IQR: 10.3–58.5), which was significantly lower compared to other patients ( p = 0.001). The diagnosis of extrapulmonary TB was significantly more common among PID patients ( p = 0.049). Treatment durations in patients with PID ranged from 6 to 24 months, and no mortality was observed.
Conclusion
Investigating PID in children diagnosed with TB may be a critical step in enabling early diagnosis and treatment before the development of potentially fatal complications. We also believe that expanding immunological investigations will contribute to a better understanding of childhood TB pathogenesis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Infectious Diseases, University of Health Sciences Dr. Behçet Uz Children's Hospital, İzmir, Turkey.
- Department of Pediatric Immunology and Allergy, University of Health Sciences Dr. Behçet Uz Children's Hospital, İzmir, Turkey.
ORCID profiles: Hincal Ozbakir, Figen Celebi Celik, Gizem Guner Ozenen, Ferah Genel
Cite
APA
Ozbakir, H., Yuksel, N. C., Ergun, D., Kacar, P., Kahraman Cetin, B., Ozer, A., Celebi Celik, F., Guner Ozenen, G., Akaslan Kara, A., Gulez, N., Genel, F., Bayram, S. N., & Devrim, İ. (2026). Tuberculosis in Children With Primary Immunodeficiencies: A 13‐Year Retrospective Experience. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71457
Vancouver
Ozbakir H, Yuksel NC, Ergun D, Kacar P, Kahraman Cetin B, Ozer A, et al. Tuberculosis in Children With Primary Immunodeficiencies: A 13‐Year Retrospective Experience. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71457
BibTeX
@article{Ozbakir2026,
author = {Ozbakir, Hincal and Yuksel, Necmi Can and Ergun, Deniz and Kacar, Pelin and Kahraman Cetin, Berna and Ozer, Arife and Celebi Celik, Figen and Guner Ozenen, Gizem and Akaslan Kara, Aybuke and Gulez, Nesrin and Genel, Ferah and Bayram, Suleyman Nuri and Devrim, İlker},
title = {Tuberculosis in Children With Primary Immunodeficiencies: A 13‐Year Retrospective Experience},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71457}
}
EUVIMED